Paragon Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,768
Closed -$1.52M 93
2025
Q1
$1.52M Buy
6,768
+156
+2% +$43K 0.57% 53
2024
Q4
$2.17M Sell
6,612
-192
-3% -$60.4K 0.74% 40
2024
Q3
$2.04M Buy
6,804
+136
+2% +$41.6K 0.66% 45
2024
Q2
$2.2M Buy
6,668
+2,152
+48% +$761K 0.8% 38
2024
Q1
$1.79M Buy
4,516
+1,428
+46% +$528K 0.72% 46
2023
Q4
$1.09M Buy
+3,088
New +$1.09M 0.46% 69
2022
Q2
Sell
-2,196
Closed -$902K 86
2022
Q1
$902K Buy
2,196
+458
+26% +$179K 0.38% 54
2021
Q4
$815K Buy
+1,738
New +$748K 0.4% 49

Other funds holding WST